Date Issued
|
Report Number
14-02079-10
No. 1
to Veterans Health Administration (VHA)
Closure Date: 10/13/2016
We recommended that processes be strengthened to ensure that the Critical Care Committee reviews each code episode, that code reviews include screening for clinical issues prior to the code that may have contributed to the occurrence of the code, and that code data is collected.
No. 2
to Veterans Health Administration (VHA)
Closure Date: 7/11/2016
We recommended that processes be strengthened to ensure that the quality of entries in the electronic health record is reviewed.
No. 3
to Veterans Health Administration (VHA)
Closure Date: 11/25/2014
We recommended that the quality control policy for scanning include how a scanned image is annotated to identify that it has been scanned.
No. 4
to Veterans Health Administration (VHA)
Closure Date: 5/5/2015
We recommended that processes be strengthened to ensure that the Blood Usage Review Committee representatives from Surgery and Anesthesia Services consistently attend meetings.
No. 5
to Veterans Health Administration (VHA)
Closure Date: 8/17/2015
We recommended that processes be strengthened to ensure that actions are implemented to address high-risk areas and that Infection Prevention Committee minutes document those actions, reflect follow-up on actions implemented to address identified problems, and consistently reflect analysis of surveillance activities.
No. 6
to Veterans Health Administration (VHA)
Closure Date: 8/17/2015
We recommended that processes be strengthened to ensure that fluoroquinolone dosages and/or medications ordered at discharge are consistent with the discharge instructions and the pharmacy updates provided to the patient/caregiver and that compliance be monitored.
No. 7
to Veterans Health Administration (VHA)
Closure Date: 2/18/2016
We recommended that processes be strengthened to ensure that clinicians provide discharge instructions to patients and/or caregivers and document this in the electronic health records and that compliance be monitored.
No. 8
to Veterans Health Administration (VHA)
Closure Date: 12/22/2016
We recommended that the facility develop an acute ischemic stroke policy that addresses all required items, that the policy be fully implemented, and that compliance be monitored.
No. 9
to Veterans Health Administration (VHA)
Closure Date: 12/22/2016
We recommended that processes be strengthened to ensure that clinicians complete and document National Institutes of Health stroke scales for each stroke patient and that compliance be monitored.
No. 10
to Veterans Health Administration (VHA)
Closure Date: 5/5/2015
We recommended that stroke guidelines be posted on the intensive care unit and the acute medical/surgical unit and that the facility provide a stroke educational program for employees.
No. 11
to Veterans Health Administration (VHA)
Closure Date: 12/22/2016
We recommended that processes be strengthened to ensure that clinicians provide printed stroke education to patients upon discharge and that compliance be monitored.
No. 12
to Veterans Health Administration (VHA)
Closure Date: 8/17/2015
We recommended that the facility collect and report to VHA the percent of eligible patients given tissue plasminogen activator, the percent of patients with stroke symptoms who had the stroke scale completed, and the percent of patients screened for difficulty swallowing before oral intake.
No. 13
to Veterans Health Administration (VHA)
Closure Date: 5/5/2015
We recommended that processes be strengthened to ensure that care plans are updated when community living center residents’ restorative care needs change and that all residents are reassessed for restorative nursing needs at the intervals required by local policy.
No. 14
to Veterans Health Administration (VHA)
Closure Date: 5/5/2015
We recommended that processes be strengthened to ensure that staff document resident progress towards restorative nursing goals, modify restorative nursing interventions as needed, and document those modifications and that compliance be monitored.
No. 15
to Veterans Health Administration (VHA)
Closure Date: 8/17/2015
We recommended that the Minimum Data Set Coordinator collaborate with the Restorative Nurse to communicate pertinent minimum data set and quality indicator data to restorative nursing program staff.
No. 16
to Veterans Health Administration (VHA)
Closure Date: 11/19/2015
We recommended that the facility establish written procedures for handling emergencies in magnetic resonance imaging and that compliance be monitored.
No. 17
to Veterans Health Administration (VHA)
Closure Date: 11/19/2015
We recommended that processes be strengthened to ensure that contrast reaction drills are conducted in magnetic resonance imaging and that compliance be monitored.
No. 18
to Veterans Health Administration (VHA)
Closure Date: 10/13/2016
We recommended that processes be strengthened to ensure that initial patient safety screenings are conducted and that compliance be monitored.
No. 19
to Veterans Health Administration (VHA)
Closure Date: 10/13/2016
We recommended that processes be strengthened to ensure that secondary patient safety screening forms are scanned into the patients’ electronic health records and that compliance be monitored.
No. 20
to Veterans Health Administration (VHA)
Closure Date: 11/19/2015
We recommended that processes be strengthened to ensure that radiologists and/or Level 2 magnetic resonance imaging personnel document resolution in patients’ electronic health records of all identified magnetic resonance imaging contraindications prior to the scan and that compliance be monitored.
No. 21
to Veterans Health Administration (VHA)
Closure Date: 5/5/2015
We recommended that processes be strengthened to ensure that all designated Level 1 ancillary staff receive annual level-specific magnetic resonance imaging safety training and that compliance be monitored.
No. 22
to Veterans Health Administration (VHA)
Closure Date: 10/13/2016
We recommended that processes be strengthened to ensure that patients with positive colorectal cancer screening test results receive diagnostic testing within the required timeframe and that compliance be monitored.